Smithers Rapra to Open New Extractables and Leachables Lab; Names Paul Cummings General Manager

Smithers Rapra, a world leader in rubber, plastics and composites testing expertise, announced today the expansion of its chemistry services with a new U.S. based extractables and leachables lab to be opened in the summer of 2017.

In addition, Paul Cummings will be joining the team as General Manager of the lab as it prepares to serve clients requiring both extractables and leachables and food contact analyses.

The new lab will add testing capacity to Smithers Rapra’s global extractables and leachables services, supporting industry growth in the medical device, pharmaceutical and food packaging industries. It will also support Smithers Rapra’s current Akron based analytical laboratory serving rubber and polymer product manufacturers. The new facility will be located at the Akron Global Business Accelerator, one of the top performing technology business incubators in the U.S.

“Introducing new testing capabilities in the U.S. will allow us to bring our highly respected services closer to our North American clients,” said Nat Leonard, President, Smithers Rapra. “Paul has an astounding amount of experience. He’s the ideal choice to lead us forward in this operation, as we continue to build our global footprint and improve our offerings in extractables and leachables testing.”

Cummings brings over 35 years of experience in chemistry and leadership in the pharmaceutical industry, most recently working as a research fellow and manager of trace organic analysis for Intertek Pharmaceutical Services. He has also worked at West Pharmaceutical, Drugscan, GlaxoSmithKline and Merck, and he holds a Bachelor of Science degree in Chemistry from Old Dominion University and a Master of Science degree in Analytical Organic Chemistry from Villanova University.

The new lab will make Smithers one of the few contract research organizations providing extractables and leachables and food contact assessments in both North America and Europe. The facility is another investment in Smithers’ long term strategy to better serve the medical device, pharmaceutical and food industries as clients continue to seek specific expertise to assist in their new product development. Already in 2017, Smithers opened a dedicated medical device testing lab in Shawbury, UK and made expansions in personnel and equipment to support migration chemistry studies at its Shawbury, UK analytical lab.